Journal article
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)-results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
TR Asmis, E Powell, CS Karapetis, DJ Jonker, D Tu, M Jeffery, N Pavlakis, P Gibbs, L Zhu, D-A Dueck, R Whittom, C Langer, CJ O'Callaghan
Annals of Oncology | OXFORD UNIV PRESS | Published : 2011
Grants
Funding Acknowledgements
TRA has acted on advisory boards for Bristol Myers Squibb, CSK has acted on advisory board and has received honoraria for seminar presentation for Merck Serono, DJJ has acted on advisory boards and has received honoraria for seminar presentation for Bristol Myers Squibb, NP has acted on advisory boards and has received honoraria and travel funding and provided expert testimony for Merck Serono, CL is an employee of Bristol Myers Squibb and owns stock in Bristol Myers Squibb.